Bluejay Diagnostics, Inc. announced that it has entered into Note Purchase Agreement with an accredited investor, and a Securities Purchase Agreement with three accredited investors. Under the terms of the NPA, an investor has agreed to provide the Company with a $1,000,000 cash subscription in exchange for the issuance of a senior secured note. The note will be repayable in an amount equal to $1,176,470, with the difference between such amount and the subscription amount being an original issue discount.

Under the terms of the SPA, the three investors have agreed to collectively provide the Company with a separate $1,000,000 cash subscription in exchange for the issuance of senior secured notes, and the collective issuance of 580,308 shares of the Company?s common stock. The notes will collectively be repayable in an amount equal to $1,111,110, with the difference between such amount and the subscription amount also being an original issue discount. The closings of the transactions are expected to occur on June 3, 2024. The notes will each mature and be repayable in cash on September 1, 2024, other than in the case of an event of default or change in control event.